Jeyaraj Pandian: Stroke Mortality in Rural Ludhiana
Jeyaraj Pandian, President of World Stroke Organization, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”New Research Published | Stroke Mortality in Rural Ludhiana
Stroke is the leading cause of death in rural Ludhiana.
Our recently published verbal autopsy study in Cureus from the Ludhiana Rural Stroke Registry analyzed 1,182 deaths across 146 villages (population 236,266) in two blocks of Ludhiana district.
Key findings:
- Stroke accounted for 262 deaths (22.2%), making it the leading cause of mortality
- Annualized crude stroke mortality rate: 55.4 per 100,000 population
- 83.6% of stroke deaths occurred within 30 days of symptom onset
- 48.1% died within the first 7 days
- Hypertension was present in 82% of stroke deaths
These findings highlight a major gap in acute stroke care services in rural communities—contributing to early deaths and preventable long‑term disability.
The way forward:
An integrated approach combining timely acute stroke care with strong prevention strategies, especially hypertension control, is urgently needed to reduce the growing stroke burden.”
Title: Stroke as the Leading Cause of Death in Rural Ludhiana, India: A Verbal Autopsy From the Population-Based Rural Stroke Registry of Ludhiana
Authors: Shavinder Singh, Clarence J. Samuel, Deepshikha Kamra, Melkey S. Bunyan, Ranjit Injety, Jeyaraj D. Pandian
Read the Full Article on Cureus

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series